Jeffrey B. Landau

Companies

• CytomX Therapeutics, Inc.Chief Business Officer Mar 28, 2022 to Aug 22, 2024¹
• CytomX Therapeutics, Inc.Chief financial officer Mar 20, 2023 to Mar 20, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CTCytomX Therapeutics, Inc. CTMX122,236 shares³$281.1K at $2.30Aug 22, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 20, 2024Sold 4,181 shares at $1.23 of CytomX Therapeutics, Inc.³
• Aug 20, 2024Exercised options 11,250 shares of CytomX Therapeutics, Inc.³
• Mar 19, 2024Sold 6,562 shares at $2.09 of CytomX Therapeutics, Inc.⁴
• Jan 18, 2024Granted 30,000 shares of CytomX Therapeutics, Inc.⁵
• Dec 20, 2023Sold 4,077 shares at $1.38 of CytomX Therapeutics, Inc.⁶
• Dec 17, 2023Exercised options 11,250 shares of CytomX Therapeutics, Inc.⁷
• Sep 22, 2023Sold 4,119 shares at $1.30 of CytomX Therapeutics, Inc.⁸
• Sep 20, 2023Granted 11,250 shares of CytomX Therapeutics, Inc.⁸
• Mar 16, 2023Sold 1,477 shares at $1.98 of CytomX Therapeutics, Inc.⁹
• Feb 2, 2023Granted 40,000 shares of CytomX Therapeutics, Inc.¹⁰
• Jul 20, 2022Sold 4,206 shares at $1.42 of CytomX Therapeutics, Inc.¹¹
• Jul 19, 2022Granted 11,250 shares of CytomX Therapeutics, Inc.¹¹